Log in to save to my catalogue

Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhi...

Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9b7fc443680149e5a3c15699e703eecb

Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway

About this item

Full title

Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway

Publisher

London: BioMed Central

Journal title

Stem cell research & therapy, 2023-09, Vol.14 (1), p.1-275, Article 275

Language

English

Formats

Publication information

Publisher

London: BioMed Central

Subjects

Subjects and topics

More information

Alternative Titles

Full title

Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9b7fc443680149e5a3c15699e703eecb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9b7fc443680149e5a3c15699e703eecb

Other Identifiers

ISSN

1757-6512

E-ISSN

1757-6512

DOI

10.1186/s13287-023-03513-2

How to access this item